Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
Acadia Expects Negative CHMP Opinion for Rett Syndrome Drug in EU
08:56am, Tuesday, 03'rd Feb 2026
ACAD expects a negative CHMP opinion on trofinetide marketing application for Rett syndrome, likely delaying a potential EU approval.
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company was informed by the Committee for Medicinal Products for Human Use (CHMP) of the European Medici
Why Acadia (ACAD) is Poised to Beat Earnings Estimates Again
01:11pm, Monday, 02'nd Feb 2026
Acadia (ACAD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
John Hussman's Strategic Moves: Qualcomm Inc. Takes Center Stage with 1.13% Portfolio Impact
01:01pm, Monday, 02'nd Feb 2026
Exploring the Investment Strategies of John Hussman (Trades, Portfolio) in Q4 2025 John Hussman (Trades, Portfolio) recently submitted the 13F filing for the f
FTRE or ACAD: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 28'th Jan 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attracti
Hussman Strategic Advisors Inc. Purchases Shares of 126,000 ACADIA Pharmaceuticals Inc. $ACAD
05:52am, Wednesday, 28'th Jan 2026
Hussman Strategic Advisors Inc. acquired a new position in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) during the undefined quarter, according to its most recent 13F filing with the Securities and Exch
SG Americas Securities LLC Raises Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD
06:33am, Tuesday, 20'th Jan 2026
SG Americas Securities LLC grew its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) by 613.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 39
Campbell & CO Investment Adviser LLC Takes $838,000 Position in ACADIA Pharmaceuticals Inc. $ACAD
04:31am, Tuesday, 20'th Jan 2026
Campbell and CO Investment Adviser LLC acquired a new position in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) during the undefined quarter, according to the company in its most recent Form 13F filing w
ACADIA Pharmaceuticals Targets $1.7B Sales by 2028, Maps Key Remlifansirin Readouts at JPM Conf
02:03am, Thursday, 15'th Jan 2026
ACADIA Pharmaceuticals (NASDAQ: ACAD) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to highlight commercial momentum from its two marketed products, outline a slate of cli
ACADIA Pharmaceuticals Inc. (ACAD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
04:05pm, Tuesday, 13'th Jan 2026
ACADIA Pharmaceuticals Inc. (ACAD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
09:00am, Tuesday, 13'th Jan 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced multiple business updates and progress on the Company's neurological and rare disease drug candidates, which will
FTRE vs. ACAD: Which Stock Is the Better Value Option?
12:42pm, Monday, 12'th Jan 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two compani
26 US stocks to watch in 2026, according to UBS
06:38am, Friday, 26'th Dec 2025
UBS has unveiled a list of 26 US stocks it considers top picks for 2026, highlighting companies poised for growth amid evolving industry trends, strategic...
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock
10:51am, Monday, 22'nd Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
04:05pm, Thursday, 18'th Dec 2025
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Ad
